Search - tctmd.com

Displaying 61 - 80 of 2554

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1369: When Watchman Isn’t Watched Enough: Rare Persistent Late Device Thrombus Despite Anticoagulation

Presenter: Ammer Aldairi

October 25, 2025

Presentation TCT 2025

TCT 1368: Percutaneous Aspiration Thrombectomy of Left Atrial Thrombus During Left Atrial Appendage Occlusion With Watchman Device

Presenter: Jevin Yabut

October 25, 2025

Presentation TCT 2025

TCT 1367: From Clot to Clear: AngioVac Extraction of Massive Left Atrial Appendage Thrombus

Presenter: Rishi Sukhija

October 25, 2025

Presentation TCT 2025

My Personal Guide to Left Atrial Thrombosis

Presenter: Pedro Arturo Villablanca

October 25, 2025

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

October 09, 2025

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

News Daily News

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

September 30, 2025

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

September 05, 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

September 01, 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

September 01, 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

August 12, 2025

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

July 24, 2025

Solid, Early Surgical Results With Polymer Mitral Valve

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

July 02, 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

News Conference News NY Valves 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

June 27, 2025

Presentation NY Valves 2025

Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications

Presenter: Robin Le Ruz

June 26, 2025

Presentation NY Valves 2025

Endocarditis Following Redo-TAVR Managed With Medical Treatment and Later TAVR-in-TAVR-in-TAVR

Presenter: Thiago Abizaid

June 26, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.